LEVOTHYROXINE SODIUM INJECTION

fresenius kabi canada ltd🇨🇦 Health Canada

Approval Id: 255fb0b1f5c33a59
Drug Approval Canada Name: LEVOTHYROXINE SODIUM INJECTION
Product Name: LEVOTHYROXINE SODIUM INJECTION
Status: Marketed
Status Date: 2022-06-10
Original Market Date: 2022-06-10
Din: 02499924
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Intramuscular , Intravenous
Schedule: Prescription
Ahfs: 68:36.04
Atc Original: H03AA01 LEVOTHYROXINE SODIUM
Atc Name: h 03 aa 01
Aig Number: 0107794005
Company Name: fresenius kabi canada ltd
Company Address: 165 Galaxy Blvd, Suite 100, Toronto, Ontario, Canada, M9W 0C8

LEVOTHYROXINE SODIUM

100 MCG / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

255fb0b1f5c33a59

Type

Standard